LETTER
Protecting-Group-Free Route to Hydroxylated Pyrrolidine and Piperidine Derivatives
2139
(8) General Procedure for the Cu(I)-Catalyzed
neous deacetylation to provide the chiral amino triol
(2S,3R,4R)-1e with a terminal alkene moiety. The copper-
catalyzed hydroamination of 1e under the conditions iden-
tical to those for Table 2, entries 2–4 and 6 furnished the
corresponding trihydroxylated piperidine derivative 2e in
53% yield (dr = 61:39) after extraction with H2O followed
by concentration to dryness (procedure C).13,17,18
Hydroamination of Amino Alkene [Procedure A with
CuOt-Bu–Xantphos (Scheme 1, Tables 1 and 2)]
In a glove box, CuOt-Bu (0.06 mmol, 8.2 mg or 0.08 mmol,
10.9 mg) and Xantphos (0.06 mmol, 34.7 mg or 0.08 mmol,
46.3 mg) were placed in a screw vial. Anhydrous, degassed
mixed solvent, MeOH–p-xylene (1:1, 0.4 mL) was added
and stirred at r.t. for 10 min to give a pale yellow solution.
A solution of a hydroxylated amino alkene (0.4 mmol) in
MeOH–p-xylene (1:1, 0.4 mL) was added. The vial was
sealed with a screw cap and was removed from the glove
box. The mixture was stirred and heated at 140 °C for 72 h.
The reaction mixture was cooled to r.t. and concentrated. An
internal standard (1,1,2,2-tetrachloroethane) was added to
the residue. The yield of the product was determined by 1H
NMR. Purification by Kugelrohr distillation or preparative
TLC (silica gel, MeOH) gave the desired product in a
practically pure form.
In summary, we have developed protecting-group-free
routes to a variety of hydroxylated pyrrolidine and piperi-
dine derivatives by way of the Cu(I)-catalyzed intramo-
lecular hydroamination of amino alcohols with a terminal
alkene moiety. The presence of one or more free hydroxy
groups in the tethering chain connecting the amine and
alkene moieties was beneficial for the cyclization to pro-
ceed efficiently. Having flexibility in introducing differ-
ent N-alkyl groups in the substrate preparation and a broad
tolerance of the copper catalysis toward various N-alkyl
groups, the present approach would possibly be a useful
alternative to the existing methods for the preparation of
N-alkyl aza-sugars.
General Procedure for the Cu(I)-Catalyzed
Hydroamination of Amino Alkene [Procedure B with
CuOAc–KOt-Bu–Xantphos (Tables 1 and 2)]
In a glove box, CuOAc (0.06 mmol, 7.4 mg or 0.08 mmol,
9.8 mg), Xantphos (0.06 mmol, 34.7 mg or 0.08 mmol, 46.3
mg), and KOt-Bu (0.09 mmol, 12.3 mg or 0.12 mmol, 16.4
mg) were placed in a screw vial. Anhydrous, degassed mixed
solvent, MeOH–p-xylene (1:1, 0.4 mL) was added and
stirred at r.t. for 10 min to give a pale yellow solution. The
following procedure is identical to that described above.
(9) The relative stereochemistry of 2bb was assigned according
to the literature. See: Andrés, J. M.; Pedrosa, R.; Pérez-
Encabo, A. Eur. J. Org. Chem. 2007, 1803.
Acknowledgment
This work was supported by Grants-in-Aid for Scientific Research
(B) from the Ministry of Education, Culture, Sports, Science and
Technology, Government of Japan.
(10) The ee of (2R,3S)-4 (95% ee) was determined by chiral
HPLC analysis of the p-nitrobenzoate derivative. See: Jäger,
V.; Hümmer, W.; Stahl, U.; Gracza, T. Synthesis 1991, 769.
(11) The ee value of (2S,3R)-6 (99% ee) was determined by the
Mosher’s NMR spectroscopic method. See: Crimmins,
M. T.; Powell, M. T. J. Am. Chem. Soc. 2003, 125, 7592.
(12) The epoxides 8 were prepared according to the reported
procedure. The ee of 8 has not been determined in our hand.
See: Takano, S.; Iwabuchi, Y.; Ogasawara, K. J. Am. Chem.
Soc. 1991, 113, 2786.
References and Notes
(1) For reviews: (a) Iminosugars as Glycosidase Inhibitors –
Nojirimycin and Beyond; Stütz, A. E., Ed.; Wiley-VCH:
Weinheim, 1999. (b) Asano, N.; Nash, R. J.; Molyneux,
R. J.; Fleet, G. W. Tetrahedron: Asymmetry 2000, 11, 1645.
(c) Lillelund, V. H.; Jensen, H. H.; Liang, X.; Bols, M.
Chem. Rev. 2002, 102, 515. (d) Pearson, M. S. M.; Mathe-
Allainmat, M.; Fargeas, V.; Lebreton, J. Eur. J. Org. Chem.
2005, 2159.
(2) For reviews on the hydroamination of alkenes and alkynes,
see: (a) Müller, T. E.; Beller, M. Chem. Rev. 1998, 98, 675.
(b) Müller, T. E.; Hultzsch, K. C.; Yus, M.; Foubelo, F.;
Tada, M. Chem. Rev. 2008, 108, 3795.
(13) The isolated 2e was contaminated with unidentified
materials. See experimental procedure in note 17.
(14) 1-Benzyl-3-hydroxy-2-methylpyrrolidine (2ac, 69:31
mixture of diastereomers)
Viscous oil. 1H NMR (300 MHz, CDCl3): d (major isomer)
= 1.22 (d, J = 6.3 Hz, 3 H), 1.66 (m, 1 H), 1.97–2.16 (m, 2
H), 2.30 (m, 1 H), 2.93 (ddd, J = 11.1, 8.4, 2.1 Hz, 1 H), 3.10
(d, J = 12.9 Hz, 1 H), 4.02 (d, J = 12.9 Hz, 1 H), 4.03 (m, 1
H), 7.23–7.35 (m, 5 H); d (minor isomer) = 1.18 (d, J = 6.3
Hz, 3 H), 1.53 (m, 1 H), 1.97–2.16 (m, 2 H), 2.41 (m, 1 H),
2.79 (ddd, J = 11.4, 8.7, 2.4 Hz, 1 H), 3.29 (d, J = 12.9 Hz, 1
H), 3.89 (m, 1 H), 3.94 (d, J = 12.9 Hz, 1 H), 7.23–7.35 (m,
5 H). 13C NMR (75 MHz, CDCl3): d = 12.84 16.25, 32.22,
32.84, 50.89, 51.24, 57.51, 57.77, 63.85, 67.26, 74.31,
78.22, 126.98, 127.01, 128.27 (2×), 128.98, 129.03, 138.99,
139.04. ESI-HRMS: m/z [M + H]+ calcd for C12H18ON:
192.1382; found: 192.1381.
(3) For late transition-metal-catalyzed intramolecular
hydroaminations of amino alkenes bearing a protecting-
group-free hydroxy group, see: Rh: (a) Liu, Z.; Hartwig,
J. F. J. Am. Chem. Soc. 2008, 130, 1570. Pt: (b) Han, X.;
Widenhoefer, R. A. Angew. Chem Int. Ed. 2006, 45, 1747.
Pd: (c) Michael, F. E.; Cochran, B. M. J. Am. Chem. Soc.
2006, 128, 4246.
(4) For intramolecular amidomercurations of amidoalkenes
bearing a protecting-group-free free hydroxy group, see:
(a) Singh, S.; Chikkanna, D.; Singh, O. V.; Han, H. Synlett
2003, 1279. (b) Chikkanna, D.; Han, H. Synlett 2004, 2311;
see also ref. 2.
(5) Ohmiya, H.; Moriya, T.; Sawamura, M. Org. Lett. 2009, 11,
2145.
(6) For reviews on the protecting-group-free synthesis, see:
(a) Hoffmann, R. W. Synthesis 2006, 3531. (b)Young, I. S.;
Baran, P. S. Nature Chem. 2009, 1, 193.
(15) (3S,4R)-3,4-Dihydroxy-1,2-dimethylpyrrolidine (2ca,
>20:1 mixture of diastereomers)
Viscous oil. 1H NMR (300 MHz, CDCl3): d = 1.15 (d, J = 6.6
Hz, 3 H), 2.26 (s, 3 H), 2.31 (m, 1 H), 2.42 (dd, J = 11.0, 6.9
Hz, 1 H), 2.97 (dd, J = 11.0, 2.7 Hz, 1 H), 4.00 (dd, J = 6.3,
5.2 Hz, 1 H), 4.22 (ddd, J = 6.9, 6.3, 2.7 Hz, 1 H). 13C NMR
(75 MHz, CDCl3): d = 12.27, 39.84, 63.42, 65.02, 69.53,
(7) For a synthesis of hydroxypyrrolidines without protecting
groups, see: Dangerfield, E. M.; Timmer, M. S. M.; Stocker,
B. L. Org. Lett. 2009, 11, 535.
Synlett 2010, No. 14, 2136–2140 © Thieme Stuttgart · New York